Xyphos focuses on creation and development of immuno-oncology therapeutics for the treatment of cancer. Xyphos was founded in 2017. Xyphos' headquarters is located in South San Francisco, California, USA 94080.
Xyphos' Co-Founder & CEO, James L. Knig... Xyphos's Co-Founder & CEO, James L. Knighton, currently has an approval
rating of 90%. Xyphos's primary competitors are Atara, Bellicum & Allogene.
There have been no acquisitions found related to Xyphos
Funding data cannot be found related to Xyphos
Recent investment data cannot be found related to Xyphos